CHTR vs ZYME · P/E 11, rev $55.09B vs rev $76.3M
Charter Communications Inc (CHTR) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Charter Communications Inc (CHTR) is a telecom services company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported CHTR revenue for 2024-12-31 was $55.09B. Net income was $5.85B. Revenue was up 0.9% from 2023-12-31 to 2024-12-31. CHTR currently screens at market cap $56.24B and trailing P/E 11.5.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
CHTR currently screens at market cap $56.24B and trailing P/E 11.5. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the CHTR and ZYME stock pages for the full models.
Not investment advice.